#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Acceleration of chemical shift encoding-based water fat MRI for liver proton density fat fraction and T2* mapping using compressed sensing


Authors: Fabian K. Lohöfer aff001;  Georgios A. Kaissis aff001;  Christina Müller-Leisse aff001;  Daniela Franz aff001;  Christoph Katemann aff002;  Andreas Hock aff002;  Johannes M. Peeters aff003;  Ernst J. Rummeny aff001;  Dimitrios Karampinos aff001;  Rickmer F. Braren aff001
Authors place of work: Institute for diagnostic and interventional Radiology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße, München, Germany aff001;  Philips Healthcare, Hamburg, Germany aff002;  Philips Healthcare, Best, Netherlands aff003
Published in the journal: PLoS ONE 14(11)
Category: Research Article
doi: https://doi.org/10.1371/journal.pone.0224988

Summary

Objectives

To evaluate proton density fat fraction (PDFF) and T2* measurements of the liver with combined parallel imaging (sensitivity encoding, SENSE) and compressed sensing (CS) accelerated chemical shift encoding-based water-fat separation.

Methods

Six-echo Dixon imaging was performed in the liver of 89 subjects. The first acquisition variant used acceleration based on SENSE with a total acceleration factor equal to 2.64 (acquisition labeled as SENSE). The second acquisition variant used acceleration based on a combination of CS with SENSE with a total acceleration factor equal to 4 (acquisition labeled as CS+SENSE). Acquisition times were compared between acquisitions and proton density fat fraction (PDFF) and T2*-values were measured and compared separately for each liver segment.

Results

Total scan duration was 14.5 sec for the SENSE accelerated image acquisition and 9.3 sec for the CS+SENSE accelerated image acquisition. PDFF and T2* values did not differ significantly between the two acquisitions (paired Mann-Whitney and paired t-test P>0.05 in all cases). CS+SENSE accelerated acquisition showed reduced motion artifacts (1.1%) compared to SENSE acquisition (12.3%).

Conclusion

CS+SENSE accelerates liver PDFF and T2*mapping while retaining the same quantitative values as an acquisition using only SENSE and reduces motion artifacts.

Keywords:

Fats – Imaging techniques – magnetic resonance imaging – Image processing – Fatty liver – Steatosis – Liver and spleen scan – Compressed sensing

Introduction

The non-invasive quantification of fat and iron content in liver tissue is of high clinical significance. For example, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease worldwide [1], with a prevalence of approximately 30% in adults in the western world [2]. In patients with NAFLD, liver damage results in hyperferritinemia and hepatic iron accumulation [3, 4]. Both hepatic iron overload and steatosis can result in fibrosis, progress to cirrhosis and therefore carry an increased risk for the development of hepatocellular carcinoma [5]. Despite availability of non-invasive imaging methods for quantification of hepatic fat and iron content, invasive tissue biopsy and histopathologic visualization of the fat deposition remains the gold standard in detection and quantification of hepatic steatosis and iron overload [612].

Magnetic resonance imaging (MRI) provides tools for fast, non-invasive quantitative imaging. Specifically, multi-echo gradient-echo acquisitions enable the simultaneous spatially-resolved mapping of the proton density fat fraction (PDFF) and T2*. Liver PDFF has emerged as a method for quantification of intrahepatic fat [1317] with high sensitivity and specificity of 95.0% and 100.0% for the detection of histologic steatosis [13]. Due to its high diagnostic performance, PDFF is used as a reference modality for other methods of image-based fat quantification like computed tomography [18]. Likewise, liver T2* mapping has emerged as a method for quantification of intrahepatic iron content [19]. Chemical shift encoding-based water-fat separation by multi-echo gradient echo acquisition enables the simultaneous accurate and precise quantification of liver PDFF and T2*.

Parallel imaging has been traditionally used to reduce acquisition times, enabling chemical shift encoding-based water-fat separation measurements in a single breath-hold. However, further reduction of the breath-hold duration is highly desirable to avoid motion artefacts and thus improve accuracy of non-invasive fat and iron quantification, especially in patients with difficulty holding their breath. Compressed sensing (CS) allows for acceleration of MRI sequences and has been successfully utilized in various applications [2022]. Some methodological works have employed CS for PDFF mapping and applied the technique in small volunteer or patient samples [2326]. However, few studies exist on the performance of CS for simultaneous PDFF and T2* mapping in larger patient cohorts.

Therefore, the purpose of this study was the evaluation of the robustness of an CS-accelerated multi-echo gradient echo acquisition for the quantification of hepatic fat and iron content compared to a standard parallel-imaging-accelerated multi-echo gradient echo acquisition in a larger patient cohort.

Material and methods

Approval by the institutional ethics committee (180/17S, Ethikkommission der Fakultät für Medizin der Technischen Universität München) was received for the study. The requirement to obtain written informed consent for retrospective data analysis was waived. All analyses were carried out in compliance with the pertinent regulations and requirements.

Patient and public involvement

We did not involve patients or the public in our work.

Patient cohort

We considered 217 datasets of patients who underwent routine clinical liver MRI examination from January 2018 until August 2018 for inclusion in the study. Datasets of patients with primary or secondary/metastatic liver tumors (N = 128) were excluded. The final patient cohort consisted of 89 patients (39 males and 50 females). Average patient age was 62.6±16.9 years (range 19–86 years). MRI was performed for the following indications: evaluation of focal pancreatic lesions (n = 57), pancreatitis (n = 15), evaluation of biliary lesions (n = 9) and suspected liver lesions (n = 8).

Data acquisition

Two variants of multi-echo gradient-echo imaging for performing chemical shift encoding-based water-fat separation were performed sequentially on each patient at a 3 T MRI scanner (Philips Ingenia Elition X; Philips Medical Systems, Best, The Netherlands). The two acquisitions were based on a spoiled gradient echo sequence using bipolar gradient readouts. The first acquisition variant used acceleration based on SENSE with a total acceleration factor equal to 2.64 (acquisition labeled as SENSE). The second acquisition variant used acceleration based on a combination of CS with SENSE with a total acceleration factor equal to 4 (acquisition labeled as CS+SENSE). The relevant scan parameters are listed in Table 1.

Tab. 1.

The CS+SENSE technique used in the present work was based on the combination of SENSE and CS, labelled as Compressed SENSE or C-SENSE. The technique uses the coil sensitivity information from a SENSE calibration scan and randomly undersamples both the central and outer part of k-space, following a smooth sampling density as moving from the center to outer parts of k-space. The acquisition and reconstruction were based on the vendor’s implementation (Compressed SENSE, Philips Healthcare). A single CS acceleration factor was defined for the CS+SENSE acquisition variant and the sampled k-space pattern (central and outer part) was defined based on the vendor’s implementation. In order to maintain a balance between noise reduction and data consistency for CS, an iterative L1-minimization reconstruction technique, forcing data fidelity, and image sparsity in the wavelet domain, was used.

Complex multi-echo gradient-echo images were generated after the SENSE and CS+SENSE reconstructions and provided as input to the fat quantification routine provided by the vendor (mDixon Quant, Philips Healthcare). Specifically, after phase correction, a complex-based water-fat decomposition was performed using a single T2* correction and a pre-calibrated fat spectrum accounting for the presence of the multiple peaks in the fat spectrum. A seven-peak fat spectrum model was employed [27]. The PDFF map was computed as the ratio of the fat signal over the sum of fat and water signals.

Image analysis

Images were reviewed by two abdominal radiologists under standardized radiological reporting room conditions. Circular regions of interest (ROI) with a diameter of 15mm were manually drawn in each liver segment in consensus, avoiding large portal vein and hepatic vein branches (Fig 1). T2* and PDFF maps were reviewed and mean ROI values and standard deviations were extracted. The software used was Sectra IDS7 (Linköping, Sweden). Motion artifacts were rated using a 4-point Likert scale as 1 = image not diagnostic because of artifacts; 2 = major artifacts; 3 = minor artifacts; 4 = no artifacts.

Fig. 1. MRI was performed for evaluation of cystic pancreatic lesion.
MRI was performed for evaluation of cystic pancreatic lesion.
Exemplary region of interest is drawn in segment VII (1.5cm). PDFF: acquisition with SENSE 11.1±2.4% (A); acquisition with CS+SENSE 10.8±1.5% (B); T2*: acquisition with SENSE 9.35±0.6ms (C); acquisition with CS+SENSE 9.28±0.5ms (D).

Statistical analysis

Variables were tested for normal distribution using the D’Agostino-Pearson omnibus K2 test. Student’s t-test was used for mean comparisons of normally distributed variables. The Wilcoxon test was used for mean comparisons of variables without normal distribution. All analyses were performed using Prism Version 7 (GraphPad Software). A two-tailed P-value below 0.05 was considered statistically significant.

Results

The use of CS+SENSE accelerated image acquisition by 35% compared to the SENSE acquisition (from 14.5 to 9.3 seconds). Mean PDFF values ranged from 4.79±5.76% (liver segment IVb) to 6.37 ± 6.65% (liver segment VII) in the acquisition with SENSE and from 5.01±5.88% (liver segment IVb) to 6.28 ± 6.10% (liver segment VII) in the acquisition with CS+SENSE. Results did not differ significantly between the two acquisitions. All values are shown in Table 2. Mean PDFF was significantly higher in the right liver lobe compared to the left in both acquisitions (right lobe: 6.04 ± 6.36%; left lobe: 5.24 ± 5.69%; P = 0.03; acquisition with SENSE and right lobe: 5.96 ± 6.30%; left lobe: 5.16 ± 5.74%; P = 0.02; acquisition with CS+SENSE).

Tab. 2.

Mean T2* values ranged from 20.54±7.05 ms (liver segment II) to 23.42±7.43 ms (liver segment V) in the acquisition with SENSE and from 21.29±8.24 ms (liver segment II) to 23.30±8.60 ms (liver segment IVb) in the acquisition with CS+SENSE. T2* values did not differ significantly between the two acquisitions. T2* values with inter-patient standard deviation and results of the mean comparison are shown in Table 3. T2* values showed no significant difference between the right and left liver lobe in both acquisitions (right lobe: 22.60 ± 7.28ms; left lobe: 21.70 ± 7.14ms; P = 0.08 in the acquisition with SENSE; right lobe: 22.65 ± 7.31ms; left lobe: 22.14 ± 7.94ms; P = 0.35; in the acquisition with CS+SENSE). Images acquired with SENSE showed minor motion artifacts in 10.1% (n = 9) and major motion artifacts in 2.2% (n = 2) of the cases. Images acquired with CS+SENSE showed minor motion artifacts in 1.1% (n = 1) of all cases. One exemplary case with hepatic steatosis, sparing segment I is shown in Fig 2. Fig 3 shows a patient with segmental steatosis. A T2 weighted image and a CT-image, acquired in the portal venous phase are shown as a comparison. Fig 4 shows a case of a patient with hepatic iron overload due to hemosiderosis.

Fig. 2. Patient with hepatic steatosis with focal fatty sparing of Segment I.
Patient with hepatic steatosis with focal fatty sparing of Segment I.
Exemplary region of interest are drawn in Segments I and VII (1.5cm). PDFF Segment I: acquisition with SENSE 25.9±3.8% (A); acquisition with CS+SENSE CS4 25.8±4.5% (B) PDFF Segment VII: acquisition with SENSE 32.2±2.0% (A); acquisition with CS+SENSE 33.2±1.6% (B).
Fig. 3. Patient with segmental hepatic steatosis.
Patient with segmental hepatic steatosis.
Exemplary regions of interest are drawn in segments IVa and V (diameter 1.5cm). PDFF Segment IVa: acquisition with SENSE 25.7±1.5% (A); acquisition with CS+SENSE 26.9±2.0% (B) PDFF Segment V: acquisition with SENSE 31.6±1.8% (A); acquisition with CS+ SENSE 32.6±2.2 (B) A T2-weighted image (C) and a CT image in the venous contrast phase (D) are shown for comparison. In CT Hounsfield units are 87±13 in Segment IVa and 42±16 in Segment V.
Fig. 4. Patient with hemosiderosis and severe reduction of T2* Exemplary region of interest is drawn in segment VII (1.5cm).
Patient with hemosiderosis and severe reduction of T2* Exemplary region of interest is drawn in segment VII (1.5cm).
T2*: acquisition with SENSE 4.03±0.8ms (A); acquisition with CS+SENSE 5.56±1.0ms (B).
Tab. 3.

Discussion

The data presented in this study show comparability of quantitative PDFF and T2* measurements acquired with compressed sensing (CS)-accelerated chemical shift encoding-based water-fat separation. Our results demonstrate a significantly higher PDFF in the right lobe of the liver, which is in accordance with other studies [28, 29], and no spatial dependence of liver T2* values.

The most important finding of the presented data is the agreement of the quantitative PDFF and T2* imaging results between the two acquisitions. Several studies have shown high accuracy of MRI-based imaging techniques for the non-invasive quantification of fat and iron content of the liver [13, 14, 29]. Due to their widespread availability, chemical shift encoding-based water-fat separation techniques can be used as a fast screening for NAFLD or disorders of iron metabolism. Given the increase of medical imaging in the last years [30], the acquisition time is an essential factor. In our study, CS+SENSE was able to accelerate image acquisition of liver PDFF and T2* mapping by 35% to a scan time of only 9.3 seconds. In a liver segment-based comparison between the acquisition with CS+SENSE and the acquisition with SENSE, no significant differences were detected in the quantitative parameters PDFF and T2*. Thus, reduction of scan time lead to a reduction of motion artifacts and did not lead to changes in quantitative parameters, rendering the presented chemical shift encoding-based water-fat separation technique combined with CS+SENSE a sequence with an excellent applicability in routine MRI liver examinations. The widespread availability could allow an application for large studies on hepatic steatosis.

Previous methodological works applied CS for the joint problem of image reconstruction and water-fat separation [2325]. The present work estimates the PDFF and T2* maps in two steps: it first applies the CS+SENSE reconstruction for the reconstruction of the multi-echo complex images and then applies water-fat separation on the reconstructed water-fat images, as also previously performed [26, 31]. Although higher acceleration factors can be achieved by solving the joint step instead of solving the problem in two steps, the present study shows that a prospective CS+SENSE accelerated acquisition using the two-step approach already results in reliable PDFF and T2* maps in the presently studied patient cohort.

Our study has some limitations. First, the study was only performed in one center and on one scanner to show the feasibility of the accelerated acquisition with CS+SENSE. We did not test the two acquisitions at different field strengths. Second, histologic correlation was not performed. However, this was not within the scope of the current study that aimed at showing robustness of quantitative parameters when using CS acceleration. Former studies have have already shown an accurate estimation of liver fat by PDFF in correlation with histologic findings [32, 33]. In addition, several previous studies have already shown high sensitivity and specificity in liver quantitative imaging with chemical shift encoding based water-fat separation techniques accounting for the same confounding factors [13, 34].

In conclusion, the acceleration of chemical shift encoding-based water-fat separation using compressed sensing results in comparable quantitative measurements of hepatic fat and iron content with reduced breath-hold intervals, leading to reduced motion artifacts and making chemical shift encoding-based water-fat separation a fast and precise non-invasive tool in quantitative liver imaging.

Supporting information

S1 Table [xlsx]


Zdroje

1. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009;32(4):741–50. doi: 10.2337/dc08-1870 19131466; PubMed Central PMCID: PMCPMC2660465.

2. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006;26(7):856–63. doi: 10.1111/j.1478-3231.2006.01311.x 16911469.

3. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007;102(6):1251–8. Epub 2007/03/30. doi: 10.1111/j.1572-0241.2007.01192.x 17391316.

4. Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, et al. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2010;138(3):905–12. Epub 2009/11/26. doi: 10.1053/j.gastro.2009.11.013 19931264.

5. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89(3):739–61. 9028304.

6. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172(7):899–905. doi: 10.1503/cmaj.045232 15795412; PubMed Central PMCID: PMCPMC554876.

7. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21. doi: 10.1002/hep.20701 15915461.

8. Sanyal AJ, American Gastroenterological A. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705–25. doi: 10.1053/gast.2002.36572 12404245.

9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–74. doi: 10.1111/j.1572-0241.1999.01377.x 10484010.

10. Sarigianni M, Liakos A, Vlachaki E, Paschos P, Athanasiadou E, Montori VM, et al. Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(1):55–63 e5. Epub 2014/07/06. doi: 10.1016/j.cgh.2014.05.027 24993364.

11. Nash S, Marconi S, Sikorska K, Naeem R, Nash G. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing. Am J Clin Pathol. 2002;118(1):73–81. doi: 10.1309/4A4U-N4GL-DRP3-EQPD 12109859.

12. Urru SA, Tandurella I, Capasso M, Usala E, Baronciani D, Giardini C, et al. Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo. Am J Hematol. 2015;90(2):87–90. doi: 10.1002/ajh.23878 25345839.

13. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251(1):67–76. doi: 10.1148/radiol.2511080666 19221054; PubMed Central PMCID: PMCPMC2663579.

14. Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18(3):337–57, ix. doi: 10.1016/j.mric.2010.08.013 21094444; PubMed Central PMCID: PMCPMC3002753.

15. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34(4):729–49. doi: 10.1002/jmri.22580 22025886.

16. Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging. 2012;36(5):1011–4. doi: 10.1002/jmri.23741 22777847; PubMed Central PMCID: PMCPMC4779595.

17. Hu HH, Kan HE. Quantitative proton MR techniques for measuring fat. NMR Biomed. 2013;26(12):1609–29. doi: 10.1002/nbm.3025 24123229; PubMed Central PMCID: PMCPMC4001818.

18. Zhang Y, Wang C, Duanmu Y, Zhang C, Zhao W, Wang L, et al. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol. 2018;91(1091):20170587. doi: 10.1259/bjr.20170587 30028193.

19. Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging. 2014;40(5):1003–21. doi: 10.1002/jmri.24584 24585403; PubMed Central PMCID: PMCPMC4308740.

20. Feng L, Benkert T, Block KT, Sodickson DK, Otazo R, Chandarana H. Compressed sensing for body MRI. J Magn Reson Imaging. 2017;45(4):966–87. doi: 10.1002/jmri.25547 27981664; PubMed Central PMCID: PMCPMC5352490.

21. Fushimi Y, Fujimoto K, Okada T, Yamamoto A, Tanaka T, Kikuchi T, et al. Compressed Sensing 3-Dimensional Time-of-Flight Magnetic Resonance Angiography for Cerebral Aneurysms: Optimization and Evaluation. Invest Radiol. 2016;51(4):228–35. doi: 10.1097/RLI.0000000000000226 26606551.

22. Zhu L, Wu X, Sun Z, Jin Z, Weiland E, Raithel E, et al. Compressed-Sensing Accelerated 3-Dimensional Magnetic Resonance Cholangiopancreatography: Application in Suspected Pancreatic Diseases. Invest Radiol. 2018;53(3):150–7. doi: 10.1097/RLI.0000000000000421 28976478.

23. Doneva M, Bornert P, Eggers H, Mertins A, Pauly J, Lustig M. Compressed sensing for chemical shift-based water-fat separation. Magn Reson Med. 2010;64(6):1749–59. doi: 10.1002/mrm.22563 20859998.

24. Sharma SD, Hu HH, Nayak KS. Accelerated T2*-compensated fat fraction quantification using a joint parallel imaging and compressed sensing framework. J Magn Reson Imaging. 2013;38(5):1267–75. doi: 10.1002/jmri.24034 23390111; PubMed Central PMCID: PMCPMC3654015.

25. Wiens CN, McCurdy CM, Willig-Onwuachi JD, McKenzie CA. R2*-corrected water-fat imaging using compressed sensing and parallel imaging. Magn Reson Med. 2014;71(2):608–16. doi: 10.1002/mrm.24699 23475787.

26. Mann LW, Higgins DM, Peters CN, Cassidy S, Hodson KK, Coombs A, et al. Accelerating MR Imaging Liver Steatosis Measurement Using Combined Compressed Sensing and Parallel Imaging: A Quantitative Evaluation. Radiology. 2016;278(1):247–56. doi: 10.1148/radiol.2015150320 26218662.

27. Ren J, Dimitrov I, Sherry AD, Malloy CR. Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. J Lipid Res. 2008;49(9):2055–62. doi: 10.1194/jlr.D800010-JLR200 18509197; PubMed Central PMCID: PMCPMC2515528.

28. Hua B, Hakkarainen A, Zhou Y, Lundbom N, Yki-Jarvinen H. Fat accumulates preferentially in the right rather than the left liver lobe in non-diabetic subjects. Dig Liver Dis. 2018;50(2):168–74. doi: 10.1016/j.dld.2017.08.030 28964678.

29. Fazeli Dehkordy S, Fowler KJ, Mamidipalli A, Wolfson T, Hong CW, Covarrubias Y, et al. Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes. European radiology. 2018. doi: 10.1007/s00330-018-5894-0 30547206.

30. Smith-Bindman R, Miglioretti DL, Larson EB. Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood). 2008;27(6):1491–502. doi: 10.1377/hlthaff.27.6.1491 18997204; PubMed Central PMCID: PMCPMC2765780.

31. Hollingsworth KG, Higgins DM, McCallum M, Ward L, Coombs A, Straub V. Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstruction. Magn Reson Med. 2014;72(6):1610–9. doi: 10.1002/mrm.25072 24347306.

32. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013;267(2):422–31. doi: 10.1148/radiol.12120896 23382291; PubMed Central PMCID: PMCPMC3632805.

33. Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013;267(3):767–75. doi: 10.1148/radiol.13121360 23382293.

34. Serai SD, Smith EA, Trout AT, Dillman JR. Agreement between manual relaxometry and semi-automated scanner-based multi-echo Dixon technique for measuring liver T2* in a pediatric and young adult population. Pediatr Radiol. 2018;48(1):94–100. doi: 10.1007/s00247-017-3990-y 29058039.


Článok vyšiel v časopise

PLOS One


2019 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#